000 01415 a2200373 4500
005 20250516081841.0
264 0 _c20120628
008 201206s 0 0 eng d
022 _a0972-2823
024 7 _a10.4103/0022-3859.93244
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRayhill, M L
245 0 0 _aGabapentin use in the prevention of succinylcholine-induced fasciculation and myalgia.
_h[electronic resource]
260 _bJournal of postgraduate medicine
_c
300 _a1-2 p.
_bdigital
500 _aPublication Type: Editorial; Comment
650 0 4 _aAmines
_xadministration & dosage
650 0 4 _aAnalgesics
_xadministration & dosage
650 0 4 _aCholecystectomy, Laparoscopic
650 0 4 _aCyclohexanecarboxylic Acids
_xadministration & dosage
650 0 4 _aFasciculation
_xprevention & control
650 0 4 _aFemale
650 0 4 _aGabapentin
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aNeuromuscular Depolarizing Agents
_xadverse effects
650 0 4 _aNeuromuscular Diseases
_xprevention & control
650 0 4 _aPain, Postoperative
_xprevention & control
650 0 4 _aSuccinylcholine
_xadverse effects
650 0 4 _agamma-Aminobutyric Acid
_xadministration & dosage
700 1 _aPerloff, M D
773 0 _tJournal of postgraduate medicine
_gvol. 58
_gno. 1
_gp. 1-2
856 4 0 _uhttps://doi.org/10.4103/0022-3859.93244
_zAvailable from publisher's website
999 _c21594489
_d21594489